1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with verapamil in 58 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (verapamil) | Trials (verapamil) | Recent Studies (post-2010) (verapamil) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 17,621 | 1,527 | 2,067 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (46.55) | 18.7374 |
| 1990's | 25 (43.10) | 18.2507 |
| 2000's | 4 (6.90) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, EA; Smith, IL | 1 |
| Balsinde, J; Fernández, B | 1 |
| Gustafson, KS; Melemed, A; Sulciner, D; Tolins, JP; Vercellotti, GM | 1 |
| Tashjian, AH; Yang, JP | 1 |
| Filep, JG; Földes-Filep, E | 1 |
| Kakishita, E; Nagai, K; Oura, Y; Suehiro, A | 1 |
| Conroy, DM; Homa, ST; Khan, SN; Smith, AD; Speak, AE | 1 |
| Bazill, GW; Dexter, TM | 1 |
| Midorikawa, Y; Ogata, H | 1 |
| Delpón, E; Diez, J; Tamargo, J | 1 |
| Pipili, E | 1 |
| Alloatti, G; Camussi, G; Emanuelli, G; Mariano, F; Montrucchio, G; Tetta, C | 1 |
| Bevan, J; Heptinstall, S | 1 |
| Bevan, J; Glusa, E; Heptinstall, S | 1 |
| Bernardini, R; Brucke, T; Calogero, AE; Chrousos, GP; Ehrlich, YH; Gold, PW | 1 |
| Gentry, PA; Liptrap, RM; Niemuller, C; Ross, ML | 1 |
| Brydun, AV; Burova, VIa; Kleĭmenova, NV; Serebrianyĭ, VL; Svetlov, SI | 1 |
| Braquet, P; Chabrier, PE; Lagente, V; Mencia-Huerta, JM | 1 |
| Bauer, C; Kurtz, A; Pfeilschifter, J | 1 |
| Avdonin, PV; Men'shikov, MIu; Orlov, SN; Pokudin, NI; Tkachuk, VA | 1 |
| Issekutz, AC; Ripley, M; Rochon, Y | 1 |
| Buxton, DB; Fisher, RA; Hanahan, DJ; Olson, MS | 1 |
| Arroyave, JL; Gonzalez-Crussi, F; Hsueh, W | 1 |
| Demopoulos, CA; Kapoulas, VM; Tselepis, A; Tsoukatos, D | 1 |
| Avdonin, PV; Svitina-Ulitina, IV; Tkachuk, VA | 1 |
| Valone, FH | 1 |
| Khan, SN; Lane, PA; Smith, AD | 1 |
| Lad, N; Lunt, DO; McCullagh, KG; Tuffin, DP; Wade, PJ | 1 |
| Belin, J; Khan, SN; Sidey, M; Smith, AD; Zilkha, KJ | 1 |
| Barrigon, S; Delgado, C; Tamargo, J; Tejerina, T | 1 |
| Clark, JS; Jubb, SN; Maloney, PJ; Young, JM | 1 |
| Lees, CJ; McCall, CE; O'Flaherty, JT; Swendsen, CL | 1 |
| Lee, TC; Malone, B; Snyder, F | 1 |
| Goldenberg, MM; Meurer, RD | 1 |
| Myers, A; Ramey, E; Ramwell, P | 1 |
| Bottecchia, D; Doni, MG; Fantin, G | 1 |
| Bárány, M; Kester, M; Ledvora, RF | 1 |
| Autore, G; Capasso, F; Di Carlo, G; Di Urno, MV; Izzo, AA; Mascolo, N | 1 |
| Arriba, G; Caramelo, C; Lamas, S; López-Novoa, JM; Olivera, A; Rodriguez-Barbero, A; Rodriguez-Puyol, D; Schrier, RW | 1 |
| Ganbo, T; Hisamatsu, K; Inoue, H; Kikushima, K; Kou, J; Kozuka, Y; Mizukoshi, A; Murakami, Y | 1 |
| Karaki, H; Kim, BK; Lee, SM; Ozaki, H | 1 |
| Bado, A; Braquet, P; Laigneau, JP; Lewin, MJ; Moizo, L; Sobhani, I; Tarrade, T | 1 |
| Brocchieri, A; Grignani, G; Moroni, M; Porta, C; Saporiti, A | 1 |
| Columbo, M; Horowitz, EM; Kagey-Sobotka, A; Lichtenstein, LM; McKenzie-White, J | 1 |
| Chiyotani, A; Isono, K; Kondo, M; Konno, K; Ozawa, Y; Takeuchi, S; Tamaoki, J | 1 |
| Diéz Marques, ML; Duque, I; Gonzalez-Rubio, M; Rodriguez Puyol, D; Rodriguez Puyol, M; Ruiz, P | 1 |
| Gardner, CR; Laskin, DL; Laskin, JD | 1 |
| Durán, WN; Hobson, RW; Kim, D; Kobayashi, I; Oshiro, H; Takenaka, H | 1 |
| Han, Q; Miller, JE; Olson, MS; Shen, F; Zhou, W | 1 |
| Kuo, HP; Liu, CY | 1 |
| López-Novoa, JM; Martínez-Salgado, C; Pérez de Lema, G; Rodríguez-Barbero, A; Rodríguez-Puyol, D | 1 |
| Hu, DH; Ma, CT | 1 |
| Goshima, M; Hori, Y; Kuroda, Y; Takase, K; Takeyama, Y; Ueda, T | 1 |
| Hanif, S; Khan, FL; Rahman, HB; Rahman, IH; Rasheed, H; Saeed, SA; Shah, BH; Shariff, AH | 1 |
| Rasheed, H; Saeed, SA | 2 |
| Kaneko, M; Liu, G; Obara, K; Tanaka, Y; Yamashita, M; Yoshioka, K | 1 |
| Liu, G; Obara, K; Tanaka, Y; Yoshioka, K | 1 |
58 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and verapamil
| Article | Year |
|---|---|
Inhibition of PAF-induced activation of human platelets by verapamil.
Topics: Adenosine Triphosphate; Blood Platelets; Calcium; Calcium Channels; Humans; Platelet Activating Factor; Platelet Activation; Thromboxane B2; Verapamil | 1992 |
Receptor-mediated activation of arachidonic acid release in mouse peritoneal macrophages is linked to extracellular calcium influx.
Topics: Animals; Arachidonic Acid; Calcium; Cells, Cultured; Egtazic Acid; Kinetics; Macrophages; Mice; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Receptors, Cell Surface; Verapamil; Zymosan | 1991 |
Calcium channel blockade inhibits platelet activating factor production by human umbilical vein endothelial cells.
Topics: Bradykinin; Cells, Cultured; Diltiazem; Endothelium, Vascular; Humans; Kinetics; Lanthanum; Platelet Activating Factor; Thrombin; Umbilical Veins; Verapamil | 1991 |
Platelet-activating factor affects cytosolic free calcium concentration and prolactin secretion in GH4C1 rat pituitary cells.
Topics: Animals; Calcium; Calcium Channels; Cell Line; Diterpenes; Dose-Response Relationship, Drug; Egtazic Acid; Ginkgolides; Kinetics; Lactones; Pituitary Neoplasms; Platelet Activating Factor; Potassium Chloride; Prolactin; Rats; Thyrotropin-Releasing Hormone; Verapamil | 1991 |
Inhibition by calcium channel blockers of the binding of platelet-activating factor to human neutrophil granulocytes.
Topics: Binding, Competitive; Calcium Channel Blockers; Cytoplasmic Granules; Diltiazem; Granulocytes; Humans; In Vitro Techniques; Indicators and Reagents; Kinetics; Neutrophils; Platelet Activating Factor; Superoxides; Verapamil | 1990 |
Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood.
Topics: Adenosine Diphosphate; Adult; Aspirin; Creatine Kinase; Drug Synergism; Humans; In Vitro Techniques; Male; Phosphocreatine; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation Inhibitors; Verapamil; Vitamin E | 1990 |
Verapamil inhibits phosphatidic acid formation and modifies phosphoinositide metabolism in stimulated platelets.
Topics: Animals; Blood Platelets; Depression, Chemical; In Vitro Techniques; Lipids; Phosphatidic Acids; Phosphatidylinositols; Phosphorus Radioisotopes; Platelet Activating Factor; Rabbits; Thrombin; Verapamil | 1990 |
Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Survival; Chloroquine; Diltiazem; Drug Synergism; Endocytosis; Furans; Humans; Hydroxyzine; In Vitro Techniques; Leukemia, Myeloid; Mice; Nifedipine; Phospholipid Ethers; Platelet Activating Factor; Pyridines; Quinidine; Quinine; Sodium Fluoride; Thiazoles; Triazoles; Verapamil | 1990 |
Agonist and antagonist of oxygen free radical.
Topics: Cells, Cultured; Endotoxins; Humans; Neutrophils; Oxygen Consumption; Platelet Activating Factor; Pyridinium Compounds; Temperature; Tetradecanoylphorbol Acetate; Verapamil | 1990 |
Effects of platelet activating factor on contractile force and 45Ca fluxes in guinea-pig isolated atria.
Topics: Action Potentials; Animals; Calcium; Calcium Radioisotopes; Cell Membrane; Diterpenes; Female; Ginkgolides; Guinea Pigs; Heart; In Vitro Techniques; Lactones; Male; Microelectrodes; Muscle Contraction; Myocardial Contraction; Myocardium; Platelet Activating Factor; Sodium; Verapamil | 1990 |
Platelet membrane potential: simultaneous measurement of diSC3(5) fluorescence and optical density.
Topics: Adenosine Diphosphate; Amiloride; Benzothiazoles; Blood Platelets; Carbocyanines; Cell Membrane; Fluorescent Dyes; Gramicidin; Humans; Membrane Potentials; Platelet Activating Factor; Platelet Aggregation; Potassium Chloride; Quinolines; Tetrodotoxin; Thrombin; Valinomycin; Verapamil | 1985 |
Protective effect of verapamil on the cardiac and circulatory alterations induced by platelet-activating factor.
Topics: Animals; Cardiovascular System; Electrocardiography; Female; Guinea Pigs; Heart; Hemodynamics; Ion Channels; Male; Myocardial Contraction; Papillary Muscles; Platelet Activating Factor; Rabbits; Verapamil | 1987 |
How can we inhibit 5-HT-induced platelet aggregation and why should we bother?
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Amlodipine; Female; Humans; Male; Middle Aged; Nifedipine; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Serotonin Antagonists; Verapamil | 1988 |
Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation.
Topics: Adenosine Diphosphate; Amlodipine; Calcium Channel Blockers; Collagen; Diltiazem; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin Antagonists; Verapamil | 1989 |
The alkyl-ether phospholipid platelet-activating factor is a stimulator of the hypothalamic-pituitary-adrenal axis in the rat.
Topics: Adrenocorticotropic Hormone; Alprazolam; Animals; Arachidonic Acid; Arachidonic Acids; Central Nervous System; Corticosterone; Corticotropin-Releasing Hormone; Diterpenes; Ginkgolides; Hypothalamo-Hypophyseal System; Hypothalamus; Lactones; Male; Pituitary Gland; Pituitary-Adrenal System; Platelet Activating Factor; Rats; Rats, Inbred Strains; Verapamil | 1989 |
Platelet aggregation in the Asian elephant is not dependent on thromboxane B2 production.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Collagen; Elephants; Female; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2; Verapamil | 1989 |
[A morphologic analysis of changes in the lungs and kidneys caused by acetyl glyceryl ether phosphorylcholine and limited by verapamil].
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Kidney; Lung; Male; Microcirculation; Platelet Activating Factor; Rabbits; Time Factors; Verapamil | 1989 |
Pharmacological modulation of the bronchopulmonary action of the vasoactive peptide, endothelin, administered by aerosol in the guinea-pig.
Topics: Aerosols; Animals; Blood Pressure; Bronchi; Diterpenes; Endothelins; Endothelium, Vascular; Ginkgolides; Guinea Pigs; Indomethacin; Lactones; Male; Nifedipine; Peptides; Plant Extracts; Platelet Activating Factor; Propranolol; Pyrilamine; Verapamil | 1989 |
Inhibition of renin secretion by platelet activating factor (acetylglyceryl ether phosphorylcholine) in cultured rat renal juxtaglomerular cells.
Topics: Animals; Calcium; Cells, Cultured; Diglycerides; Juxtaglomerular Apparatus; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Platelet Activating Factor; Rats; Renin; Type C Phospholipases; Verapamil | 1985 |
[Mechanism of increase in Ca2+ level in platelet cytoplasm induced by aggregating factors].
Topics: Alprostadil; Blood Coagulation Factors; Blood Platelets; Calcium; Cyclic AMP; Cytoplasm; Fluorescent Dyes; Humans; In Vitro Techniques; Platelet Activating Factor; Verapamil | 1985 |
Synergistic inhibition of complement induced granulocyte margination by BW755C and calcium channel blockers.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Agranulocytosis; Animals; Calcium; Calcium Channel Blockers; Cell Aggregation; Chemotactic Factors; Complement System Proteins; Female; Granulocytes; In Vitro Techniques; Leukotriene B4; Lipoxygenase Inhibitors; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Pyrazoles; Rabbits; Verapamil | 1985 |
Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver.
Topics: Adenosine Diphosphate; Calcium; Cyclic AMP; Dose-Response Relationship, Drug; Glucose; Hemodynamics; Liver Glycogen; Oxygen Consumption; Perfusion; Platelet Activating Factor; Portal Vein; Vasoconstriction; Venous Pressure; Verapamil | 1986 |
Platelet-activating factor-induced ischemic bowel necrosis. An investigation of secondary mediators in its pathogenesis.
Topics: Alprostadil; Animals; Blood Pressure; Catechols; Chromones; Diethylcarbamazine; Disease Models, Animal; Hematocrit; Indomethacin; Intestines; Ischemia; Leukocyte Count; Lipopolysaccharides; Lipoxygenase Inhibitors; Male; Masoprocol; Methacrylates; Necrosis; Platelet Activating Factor; Rats; Rats, Inbred Strains; Salmonella typhi; Thromboxane-A Synthase; Verapamil | 1986 |
Effects of AGEPC on the intracellular levels of ions in Tetrahymena pyriformis.
Topics: Calcium; Platelet Activating Factor; Potassium; Sodium; Tetrahymena pyriformis; Verapamil | 1986 |
Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine.
Topics: Blood Platelets; Calcium; Cytosol; Humans; Nicardipine; Platelet Activating Factor; Spectrometry, Fluorescence; Verapamil | 1988 |
Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers.
Topics: Adult; Blood Platelets; Calcium Channel Blockers; Diltiazem; Humans; Platelet Activating Factor; Platelet Aggregation; Protein Binding; Verapamil | 1987 |
Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium Channel Blockers; Egtazic Acid; Gallic Acid; In Vitro Techniques; Lanthanum; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Proteins; Rabbits; Serotonin; Verapamil | 1985 |
Effect of calcium and calcium antagonists on [3H]-Paf-acether binding to washed human platelets.
Topics: Benzazepines; Blood Platelets; Buffers; Calcium; Calcium Channel Blockers; Diltiazem; Humans; Male; Nifedipine; Platelet Activating Factor; Platelet Aggregation; Statistics as Topic; Stereoisomerism; Tritium; Verapamil | 1986 |
Response to platelet-activating factor of platelets from patients with multiple sclerosis.
Topics: Acetophenones; Blood Platelets; Calcium; Humans; Indomethacin; Multiple Sclerosis; Platelet Activating Factor; Platelet Aggregation; Verapamil | 1985 |
Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles.
Topics: Action Potentials; Animals; Calcium; Dose-Response Relationship, Drug; Guinea Pigs; In Vitro Techniques; Myocardial Contraction; Papillary Muscles; Platelet Activating Factor; Tetraethylammonium Compounds; Verapamil | 1985 |
Pharmacological investigation of the mechanisms of platelet-activating factor induced mortality in the mouse.
Topics: Anaphylaxis; Animals; Chloroquine; Chlortetracycline; Dexamethasone; Dose-Response Relationship, Drug; Female; Indomethacin; Injections, Intravenous; Male; Mice; Mice, Inbred DBA; Naproxen; Nicardipine; Nifedipine; Platelet Activating Factor; Pyrazoles; Quinacrine; Tetracycline; Verapamil | 1985 |
Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine.
Topics: Animals; Calcium; Calcium Channel Blockers; Cytochalasin B; Extracellular Space; Glucuronidase; Ion Channels; Kinetics; Lysophosphatidylcholines; Lysosomes; Magnesium; Neutrophils; Platelet Activating Factor; Rabbits; Verapamil | 1981 |
Stimulation of calcium uptake by 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) in rabbit platelets: possible involvement of the lipoxygenase pathway.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Biological Transport, Active; Blood Platelets; Calcium; Indomethacin; Platelet Activating Factor; Rabbits; Verapamil | 1983 |
A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat.
Topics: Animals; Carrageenan; Dexamethasone; Dose-Response Relationship, Drug; Edema; Hindlimb; Indomethacin; Male; Muscles; Phentolamine; Platelet Activating Factor; Rats; Rats, Inbred Strains; Regional Blood Flow; Theophylline; Verapamil; Yohimbine | 1984 |
Glucocorticoid protection against PAF-acether toxicity in mice.
Topics: Animals; Cortisone; Female; Glucocorticoids; Indomethacin; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Sex Factors; Verapamil | 1983 |
Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation.
Topics: Animals; Blood Physiological Phenomena; Clot Retraction; Depression, Chemical; Dipyridamole; Dose-Response Relationship, Drug; Humans; Isotonic Solutions; Malondialdehyde; Platelet Activating Factor; Platelet Aggregation; Rats; Verapamil | 1984 |
The potentiation of arterial contraction with platelet activating factor.
Topics: Animals; Calmodulin; Carotid Arteries; Flurbiprofen; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Activating Factor; Potassium Chloride; Sodium Chloride; Swine; Verapamil | 1984 |
Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents.
Topics: Animals; Bradykinin; Carrageenan; Cellulose; Dextrans; Dinoprostone; Diterpenes; Drug Synergism; Edema; Ginkgolides; Histamine; Inflammation Mediators; Lactones; Male; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Rats; Rats, Wistar; Serotonin; Verapamil | 1994 |
Effect of atrial natriuretic peptide and calcium antagonists on platelet-activating factor-induced contraction and intracellular calcium mobilization in rat mesangial cells.
Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Calcium; Calcium Channel Blockers; Cells, Cultured; Diterpenes; Dose-Response Relationship, Drug; Fura-2; Furans; Gallic Acid; Ginkgolides; Glomerular Mesangium; Hydrogen-Ion Concentration; Lactones; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Rats, Wistar; Spectrometry, Fluorescence; Verapamil | 1994 |
Effect of ibudilast on ciliary activity of human paranasal sinus mucosa in vitro.
Topics: Bronchodilator Agents; Cilia; Humans; In Vitro Techniques; Indomethacin; Leukotriene D4; Mucociliary Clearance; Nasal Mucosa; Paranasal Sinuses; Platelet Activating Factor; Propranolol; Pyridines; Verapamil | 1995 |
Increased sensitivity of rat myometrium to the contractile effect of platelet activating factor before delivery.
Topics: Animals; Calcium; Calcium Channel Blockers; Female; In Vitro Techniques; Myometrium; Platelet Activating Factor; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Uterine Contraction; Verapamil | 1995 |
Platelet-activating factor stimulates gastric acid secretion in isolated rabbit gastric glands.
Topics: Aminopyrine; Animals; Azepines; Biological Transport; Calcium; Carbachol; Dose-Response Relationship, Drug; Egtazic Acid; Famotidine; Fluorescent Dyes; Gastric Acid; Gastric Mucosa; Histamine; In Vitro Techniques; Kinetics; Male; Platelet Activating Factor; Rabbits; Thiazoles; Thienopyridines; Triazoles; Verapamil | 1995 |
Effect of different platelet agonists on intracellular free Ca++ concentrations in human tumor cells: possible role in tumor growth.
Topics: Adenosine Diphosphate; Adult; Blood Coagulation; Blood Platelets; Calcium; Cell Communication; Cell Division; Collagen; HeLa Cells; Humans; Intracellular Fluid; Leukotriene B4; Melanoma; Mesothelioma; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet-Derived Growth Factor; Thrombin; Thromboxane B2; Tumor Cells, Cultured; Verapamil | 1995 |
Pharmacologic control of histamine release from human basophils induced by platelet-activating factor.
Topics: 1-Methyl-3-isobutylxanthine; Basophils; Cyclic AMP; Enzyme Inhibitors; Histamine Release; Humans; Pertussis Toxin; Platelet Activating Factor; Verapamil; Virulence Factors, Bordetella | 1993 |
Effect of platelet-activating factor on intracellular free calcium in cow tracheal epithelium.
Topics: Animals; Bradykinin; Calcium; Cattle; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Fura-2; Inositol 1,4,5-Trisphosphate; Platelet Activating Factor; Pyridinium Compounds; Trachea; Verapamil | 1994 |
Calcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.
Topics: Animals; Calcium Channel Blockers; Cell Count; Cell Division; Cells, Cultured; Diltiazem; Diterpenes; Ginkgolides; Glomerular Mesangium; Hydrogen Peroxide; Kinetics; Lactones; Platelet Activating Factor; Platelet-Derived Growth Factor; Rats; Rats, Wistar; Thrombin; Thymidine; Tritium; Verapamil | 1993 |
Platelet-activating factor-induced calcium mobilization and oxidative metabolism in hepatic macrophages and endothelial cells.
Topics: Alprazolam; Animals; Calcium; Cells, Cultured; Endothelium; Female; Kinetics; Kupffer Cells; Liver; Oxygen Consumption; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Superoxides; Tetradecanoylphorbol Acetate; Triazolam; Verapamil | 1993 |
L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo.
Topics: Animals; Calcium Channel Blockers; Capillary Permeability; Cricetinae; Dextrans; Fluorescein-5-isothiocyanate; Male; Mesocricetus; Nifedipine; Platelet Activating Factor; Spectrometry, Fluorescence; Vasoconstriction; Verapamil | 1995 |
Evidence for altered cellular calcium in the pathogenetic mechanism of acute pancreatitis in rats.
Topics: Acute Disease; Animals; Calcium; Calcium Channel Blockers; Ceruletide; Drug Synergism; Male; Pancreas; Pancreatitis; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Thromboxane B2; Verapamil | 1996 |
The different effect of salbutamol and aminophylline on platelet activating factor-induced plasma exudation into guinea pig tracheal wall and lumen.
Topics: Adrenergic beta-Agonists; Albuterol; Aminophylline; Animals; Bronchodilator Agents; Capillary Permeability; Guinea Pigs; Male; Platelet Activating Factor; Trachea; Verapamil | 1996 |
Involvement of phospholipase A2 in gentamicin-induced rat mesangial cell activation.
Topics: Acetates; Animals; Aristolochic Acids; Cell Division; Cell Survival; Cells, Cultured; Dinoprostone; Diterpenes; DNA; Enzyme Inhibitors; Gentamicins; Ginkgolides; Glomerular Mesangium; Kinetics; Lactones; Phenanthrenes; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinacrine; Rats; Rats, Wistar; Thymidine; Verapamil | 1997 |
[Effect of platelet activating factor on TxA2, PGI2 and Ca(2+)-ATPase activity in the intra-pulmonary artery smooth muscle cells].
Topics: Animals; Calcium-Transporting ATPases; Cells, Cultured; Epoprostenol; Indomethacin; Muscle, Smooth, Vascular; Platelet Activating Factor; Pulmonary Artery; Rabbits; Thromboxane A2; Verapamil | 1996 |
Pancreatitis-associated ascitic fluid increases intracellular Ca(2+) concentration on hepatocytes.
Topics: Acute Disease; Animals; Ascitic Fluid; Calcium; Cells, Cultured; Dogs; Egtazic Acid; Liver; Male; Multiple Organ Failure; Pancreatitis; Platelet Activating Factor; Rats; Rats, Wistar; Verapamil | 2000 |
Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine.
Topics: Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Estrenes; Flavonoids; Humans; In Vitro Techniques; Indomethacin; Kinetics; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Pyrrolidinones; Serotonin; Thromboxane A2; Verapamil | 2001 |
Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Azepines; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Drug Synergism; Epinephrine; Flurbiprofen; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Signal Transduction; Triazoles; Verapamil; Yohimbine | 2003 |
Involvement of thromboxane A2 and tyrosine kinase in the synergistic interaction of platelet activating factor and calcium ionophore A23187 in human platelet aggregation.
Topics: Benzoquinones; Blood Platelets; Calcimycin; Humans; Indomethacin; Ionophores; Lactams, Macrocyclic; Platelet Activating Factor; Platelet Aggregation; Protein-Tyrosine Kinases; Quinones; Rifabutin; Thromboxane A2; Verapamil | 2004 |
Platelet-activating factor (PAF) enhances guinea pig detrusor smooth muscle contractile activities by stimulating voltage-dependent Ca
Topics: Animals; Calcium; Calcium Channels; Guinea Pigs; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Verapamil | 2023 |
Pharmacological Studies on the Ca
Topics: Animals; Calcium; Calcium Channels, L-Type; Female; Mice; Muscle Contraction; Platelet Activating Factor; Pregnancy; Urinary Bladder; Verapamil | 2023 |